-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ABMyvYHrTAy5CFTKZgXSy/0jU0at1yJe6lZlnFLc9dUPXET6Wp8ITjpZSqE8jIil IMieI1CfIYvttz0XTdN2rQ== /in/edgar/work/0000950130-00-006211/0000950130-00-006211.txt : 20001121 0000950130-00-006211.hdr.sgml : 20001121 ACCESSION NUMBER: 0000950130-00-006211 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20001120 ITEM INFORMATION: FILED AS OF DATE: 20001120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BECTON DICKINSON & CO CENTRAL INDEX KEY: 0000010795 STANDARD INDUSTRIAL CLASSIFICATION: [3841 ] IRS NUMBER: 220760120 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 001-04802 FILM NUMBER: 773943 BUSINESS ADDRESS: STREET 1: ONE BECTON DR CITY: FRANKLIN LAKES STATE: NJ ZIP: 07417-1880 BUSINESS PHONE: 2018476800 MAIL ADDRESS: STREET 1: ONE BECTON DR CITY: FRANKLIN LAKE STATE: NJ ZIP: 07417 8-K 1 0001.txt FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 20, 2000 ----------------- BECTON, DICKINSON AND COMPANY - -------------------------------------------------------------------------------- (Exact name of registrant as specified in its charter) New Jersey 001-4802 22-0760120 - -------------------------------------------------------------------------------- (State or other juris- (Commission (IRS Employer Iden- diction of incorporation) File Number) tification Number) 1 Becton Drive, Franklin Lakes, New Jersey 07417-1880 - -------------------------------------------------------------------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (201) 847-6800 -------------- N/A - -------------------------------------------------------------------------------- (Former name or former addresses if changed since last report.) Item 9. Regulation FD Disclosure See the supplemental financial information attached hereto as Exhibit 99, which is incorporated herein by reference. INDEX TO EXHIBITS ----------------- Exhibit Number Description of Exhibits ------ ----------------------- 99 Supplemental Financial Information EX-99 2 0002.txt SUPPLEMENTAL FINANCIAL INFORMATION BD FY 2000 Revenues by Business Segments and Major Product Groups Quarter 4 Total Year ----------------------- -------------------- % Growth % Growth ----------------------- -------------------- Total US Int'l Total US Int'l ----------------------- -------------------- Medical Injection System -0.7% -7.5% 5.6% 5.8% 4.6% 7.0% Infusion Therapy Systems -5.1% -10.6% -1.5% 2.1% 10.6% -3.3% Consumer Health Care -10.7% -16.0% 2.6% -1.5% -7.4% 9.3% Pharmaceutical Systems 13.6% 39.6% 7.8% 7.1% 14.9% 5.5% Other -5.1% -9.7% 0.1% -2.9% -2.6% -3.2% ----------------------- -------------------- -3.4% -10.0% 3.4% 2.2% 0.5% 3.7% Preanalytical Solutions 2.2% 0.2% 4.7% 5.1% 4.4% 6.0% Biosciences Flow Cytometry 35.1% 44.7% 24.4% 36.3% 57.4% 15.7% Microbiolgy 2.2% 0.5% 4.5% 2.7% 3.0% 2.4% Labware 0.5% -3.3% 5.9% 6.2% 6.0% 6.4% ----------------------- -------------------- 12.7% 13.5% 11.7% 13.4% 18.1% 7.5% ----------------------- -------------------- Total Company 1.9% -1.4% 5.8% 5.8% 6.6% 5.0% ======================= ==================== BD FY 2000 Revenues by Business Segments and Major Product Groups ($ in Millions) Quarter 4 Total Year ----------------------- ---------------------- Amount Amount ----------------------- ---------------------- Total US Int'l Total US Int'l ----------------------- ---------------------- Medical Injection System $153 $ 68 $ 84 $ 609 $ 295 $ 314 Infusion Therapy Systems 79 30 50 342 144 198 Consumer Health Care 143 96 47 505 307 198 Pharmaceutical Systems 66 15 51 255 48 207 Other 61 30 31 255 134 121 ----------------------- ---------------------- 502 239 263 1,966 927 1,039 Preanalytical Solutions 131 71 59 535 292 243 Biosciences Flow Cytometry 113 64 49 407 232 175 Microbiolgy 137 78 59 568 332 236 Labware 37 21 16 143 81 62 ----------------------- ---------------------- 287 163 124 1,118 644 473 ----------------------- ---------------------- Total Company $920 $474 $446 $3,618 $1,864 $1,755 ======================= ====================== -----END PRIVACY-ENHANCED MESSAGE-----